Literature DB >> 11747357

Splenic and peritoneal B-1 cells differ in terms of transcriptional and proliferative features that separate peritoneal B-1 from splenic B-2 cells.

G M Fischer1, L A Solt, W D Hastings, K Yang, R M Gerstein, B S Nikolajczyk, S H Clarke, T L Rothstein.   

Abstract

B-1 cells constitute a distinct B cell subset with characteristic phenotypic and functional features. B-1 cells are highly represented among peritoneal lymphocytes; substantial numbers of B-1 cells are also located within splenic tissue. Here a number of differences in transcription factor and gene expression were identified that separate peritoneal B-1 and splenic B-2 cells, and then splenic B-1 cells obtained from immunoglobulin transgenic mice were tested for these parameters. Splenic B-1 cells resembled splenic B-2 cells rather than peritoneal B-1 cells in terms of nuclear expression of DNA-binding STAT3, CREB, and PU.1, with respect to transcriptional activation of IL-10, and in the failure to enter cell cycle in response to PMA. Splenic B-1 cells (B-1S) appear to constitute a unique population of B-1 cells, which, while sharing with peritoneal B-1 cells (B-1P) certain phenotypic features, differ from them in transcription factor and gene expression and in signaling for cell cycle progression. (c)2001 Elsevier Science.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11747357     DOI: 10.1006/cimm.2001.1860

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  13 in total

1.  Interleukin-10 mediated autoregulation of murine B-1 B-cells and its role in Borrelia hermsii infection.

Authors:  Vishal Sindhava; Michael E Woodman; Brian Stevenson; Subbarao Bondada
Journal:  PLoS One       Date:  2010-07-06       Impact factor: 3.240

2.  Type I Interferon Counteracts Antiviral Effects of Statins in the Context of Gammaherpesvirus Infection.

Authors:  Philip T Lange; Eric J Darrah; Emily P Vonderhaar; Wadzanai P Mboko; Michaela M Rekow; Shailendra B Patel; Duska J Sidjanin; Vera L Tarakanova
Journal:  J Virol       Date:  2016-01-06       Impact factor: 5.103

Review 3.  Killer B lymphocytes: the evidence and the potential.

Authors:  Steven K Lundy
Journal:  Inflamm Res       Date:  2009-03-05       Impact factor: 4.575

4.  Expression of plasma cell alloantigen 1 defines layered development of B-1a B-cell subsets with distinct innate-like functions.

Authors:  Hongsheng Wang; Dong-Mi Shin; Sadia Abbasi; Shweta Jain; Alexander L Kovalchuk; Natalie Beaty; Sophia Chen; Ines Gonzalez-Garcia; Herbert C Morse
Journal:  Proc Natl Acad Sci U S A       Date:  2012-11-19       Impact factor: 11.205

5.  Immunoglobulin secretion by B1 cells: differential intensity and IRF4-dependence of spontaneous IgM secretion by peritoneal and splenic B1 cells.

Authors:  Nichol E Holodick; Joseph R Tumang; Thomas L Rothstein
Journal:  Eur J Immunol       Date:  2010-10-27       Impact factor: 5.532

6.  Continual signaling is responsible for constitutive ERK phosphorylation in B-1a cells.

Authors:  Nichol E Holodick; Joseph R Tumang; Thomas L Rothstein
Journal:  Mol Immunol       Date:  2009-07-09       Impact factor: 4.407

7.  B cells in murine cervical lymph nodes are conventional B-2 cells.

Authors:  Seung Geun Yeo; Joong Saeng Cho; Dong Choon Park
Journal:  J Korean Med Sci       Date:  2006-06       Impact factor: 2.153

8.  NIM-R7, a novel marker for resting B1 and marginal-zone B lymphocytes, is also expressed on activated T and B cells.

Authors:  Nataly Manjarrez-Orduño; R Michael E Parkhouse; Leopoldo Santos-Argumedo
Journal:  Immunology       Date:  2003-06       Impact factor: 7.397

Review 9.  Human B-1 cells take the stage.

Authors:  Thomas L Rothstein; Daniel O Griffin; Nichol E Holodick; Tam D Quach; Hiroaki Kaku
Journal:  Ann N Y Acad Sci       Date:  2013-05       Impact factor: 5.691

10.  CD19 signaling is impaired in murine peritoneal and splenic B-1 B lymphocytes.

Authors:  Trivikram Dasu; Vishal Sindhava; Stephen H Clarke; Subbarao Bondada
Journal:  Mol Immunol       Date:  2009-06-21       Impact factor: 4.407

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.